Trial Profile
Use of Fondaparinux in Critically Ill Patients With Renal Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions
- 18 Jun 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 10 Nov 2011 New trial record